The PHOTOSINT project presents solutions to the challenges chemical industries are facing in integrating renewable energy sources into their processes. The project will deliver sustainable processes to produce hydrogen and methanol as energy vectors using only sunlight as an energy source and wastewater and CO2 as feedstocks, making the industries more auto-sufficient. The pathway is based on solar-driven artificial photosynthesis, and aims to develop new catalytic earth-abundant materials and modifications of existing ones to improve catalytic processes. Design parameters of the PEC cell will be tuned to maximize solar to fuel (STF) efficiency. Moreover to improve the conversion for industrial implementation, PHOTOSINT will develop a novel way to concentrate and illuminate the semiconductor surface to maximize overall energy efficiency. Perovskite solar PV cells will be integrated to harvest the light to supply the external electrical voltage. PHOTOSINT is an ambitious project due to precedents in research conducted to date and the low production rate of the desired products. For integrating sunlight energy into the industry, the catalyst will be studied, and then the best one/s will be implemented in prototypes. The obtained results will be used for making scale-up in pilots with tandem PEC cells. These steps are necessary to assess the industrial scale-up feasibility, promoting the increased competitiveness of renewable process energy technologies and energy independence. MeOH and H2 will be tested in engines. Also, an HTPEM fuel cell will be used for electricity generation, and hydrogen will be tested as an alternative fuel for energy generation instead natural gas in melting furnaces avoiding CO2 emissions.

ESTELLA is an ambitious initiative that proposes an innovative solution to improve the recyclability of low-recyclable materials: thermosetting composites. To this end, ESTELLA will work on the design of novel bio-based epoxy resins with inherent recyclability capabilities thanks to the introduction of Covalent Adaptive Network (CAN) in the original epoxy structure. CAN will provide the thermosetting epoxy resin with the ability to respond to certain stimulus that changes the state of its microstructure and thus, the ability to be reprocessed/re-polymerized (return to original monomers and fibres). A similar strategy will be applied to existing fossil-based epoxy formulations. In this way, the thermoset can be reprocessed or re-polymerized into new products and the fibres can be recovered as well. In addition, fibres of renewable origin will be used as reinforcement to manufacturing thermoset composites. ESTELLA research will address recycling techniques of any nature (chemical, biological and mechanical) to guarantee that the materials developed during the project can be successfully separated into their components in a safe and cost-effective way, hence maximizing the revenue of recycling activities. The validation of the developed recyclable materials will be carried out through economically and environmentally efficient manufacture processes (out-of-autoclave). Thus, new bio-composites will be designed and developed based on the premises of improving recyclability while meeting the demands of different sectors such as construction and leisure/mobility. Also, extensive work will be carried out to leverage the industrial application of the technologies and materials developed, taking into account safety, techno-economic, regulatory and intellectual property aspects.

Cell and gene therapies offer a massive paradigm shift from current treatment options and hold the potential to cure previously untreatable diseases. Naturally-occurring and genetically modified T cells with chimeric antigen (CAR) or T cell receptors (TCR) have demonstrated remarkable curative capacities against advanced hematologic malignancies but have shown limited efficacy in treating solid tumors. Major barriers hindering the full antitumor potential of T cells are the immunosuppressive signals and persisting antigenic stimuli within the tumor microenvironment that inexorably push T cells into a highly dysfunctional state called “exhaustion”. Herein, we propose a groundbreaking technology, T-FITNESS, which will enable antitumor T cells to become refractory to exhaustion. At the core of the platform are microRNA (miRNA)-based synthetic logic circuits capable of rewiring the transcriptional networks orchestrating T cell exhaustion. By harnessing the power of CRISPR/Cas genome editing, we will integrate sensors of miRNAs upregulated in exhausted cells into untranslated regions of one or more transcription factors driving T cell exhaustion, to enable their fine-tuned downregulation. We will validate the reprogramming efficacy of T-FITNESS by performing extensive functional analyses in vitro and in vivo and advance the best circuits towards the clinic by developing an automated cGMP-compliant manufacturing process for point-of-care production of T-FITNESS-edited CAR-T cells. To develop this innovative platform, we will bring together a multidisciplinary consortium of academic and industry partners that combine their unique expertise in T cell therapy and immunology, synthetic biology, genome editing, cGMP manufacturing, bioinformatics, and communication. Easily integrable within CAR-T, TCR-T, and tumor-infiltrating lymphocyte (TIL) platforms, T-FITNESS will unleash the curative potential of T cell therapy for the benefit of an ever-growing number of cancer patients.

EU Mission for Adaptation to Climate Change perceives the improved dryland agriculture as one of the ways to adapt and survive. Humans have the technology and processes to address the major agricultural issues today, such as pest infestation, droughts, the misuse of herbicides; however, the global warming requires a new set of tools and the willingness to adapt from all of us. The key developmental switch for the flower/fruit bearing plants is the change from vegetative to reproductive growth, and the timing is crucial. The climate changes have been already impacting the flowering, as several perennial and annual crops have flowered earlier by about 2 days per decade, during the last 50 years. The flowering locus T is a plant protein highly recognized as a part of the florigen complex, a mobile protein that is produced in the leaf companion cells and transported to the plant shoot apex to induce flowering. My previous work was focused on the FT preference to bind to phosphatidylglycerol (PG), over other lipid species, in the temperature-dependent manner, and the impact on the flowering time. The MSCA Project will address the relevance of the wider array of FT-PG interactions, by utilizing the genetic modifications to produce and characterize the FT mutant proteins with enhanced lipid-binding properties. The super sticky FT would be difficult to remove from the membrane, which could have a potential industrial application. A challenge would be to create the protein that could not bind to the membrane, which will shed a new light onto flowering regulation. The multidisciplinary approach, consisting of molecular biology, biochemistry, structural chemistry, and biophysics, will produce deliverables for the subsequent in planta project. The measured impact of different ambient temperatures will provide us with the knowledge of the fine-tuning and control over the protein-lipid interactions, which could have the long-standing effects in the agricultural applications.